Clinical implications of the “personal” genome Ali J. Marian Invited Commentary 16 October 2008 Pages: 361 - 363
Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention Deepak L. Bhatt Clinical Trials Report 16 October 2008 Pages: 367 - 368
Is it LDL particle size or number that correlates with risk for cardiovascular disease? H. Robert SuperkoRadhika R. Gadesam OriginalPaper 16 October 2008 Pages: 377 - 385
Triglycerides and risk for coronary artery disease Patrick McBride OriginalPaper 16 October 2008 Pages: 386 - 390
Carotid artery disease: Stenting versus endarterectomy Andreas KastrupSonja SchnaudigelKlaus Gröschel OriginalPaper 16 October 2008 Pages: 391 - 397
Rosiglitazone and cardiovascular risk Sanjay KaulGeorge A. Diamond OriginalPaper 16 October 2008 Pages: 398 - 404
HDL therapy for cardiovascular diseases: the road to HDL mimetics C. Roger WhiteGeeta DattaG. M. Anantharamaiah OriginalPaper 16 October 2008 Pages: 405 - 412
Effect of ABCA1 mutations on risk for myocardial infarction Iulia IatanKhalid AlrasadiJacques Genest OriginalPaper 16 October 2008 Pages: 413 - 426
Migraine with and without aura and risk for cardiovascular disease Bert B. VargasDavid W. DodickBart M. Demaerschalk OriginalPaper 16 October 2008 Pages: 427 - 433
Revascularization treatment recommendations based on atherosclerotic disease distribution: Coronary artery bypass grafting versus stenting Kim I. de la CruzPeter I. TsaiDenton A. Cooley OriginalPaper 16 October 2008 Pages: 434 - 437
Coronary artery calcium scoring in the age of CT angiography: What is its role? Paolo RaggiAkbar KhanArthur E. Stillman OriginalPaper 16 October 2008 Pages: 438 - 443
Carotid intima-media thickness measurements: Techniques and clinical relevance Blai CollSteven B. Feinstein OriginalPaper 16 October 2008 Pages: 444 - 450